Neuronetics, Inc. (STIM)

USD 1.37

(5.38%)

Operating Expenses Summary of Neuronetics, Inc.

  • Neuronetics, Inc.'s latest annual operating expenses in 2023 was 82.25 Million USD , down -5.4% from previous year.
  • Neuronetics, Inc.'s latest quarterly operating expenses in 2024 Q2 was 20.13 Million USD , up 6.7% from previous quarter.
  • Neuronetics, Inc. reported a annual operating expenses of 84.83 Million USD in annual operating expenses 2022, up 19.11% from previous year.
  • Neuronetics, Inc. reported a annual operating expenses of 71.22 Million USD in annual operating expenses 2021, up 18.71% from previous year.
  • Neuronetics, Inc. reported a quarterly operating expenses of 19.38 Million USD for 2024 Q1, down -1.56% from previous quarter.
  • Neuronetics, Inc. reported a quarterly operating expenses of 20.63 Million USD for 2023 Q3, up 2.54% from previous quarter.

Annual Operating Expenses Chart of Neuronetics, Inc. (2023 - 2016)

Historical Annual Operating Expenses of Neuronetics, Inc. (2023 - 2016)

Year Operating Expenses Operating Expenses Growth
2023 82.25 Million USD -5.4%
2022 84.83 Million USD 19.11%
2021 71.22 Million USD 18.71%
2020 59.99 Million USD -19.14%
2019 74.19 Million USD 23.33%
2018 60.16 Million USD 35.47%
2017 44.4 Million USD 20.21%
2016 36.94 Million USD 0.0%

Peer Operating Expenses Comparison of Neuronetics, Inc.

Name Operating Expenses Operating Expenses Difference
Bionano Genomics, Inc. 148.99 Million USD 44.79%
Prenetics Global Limited 60.73 Million USD -35.436%
Star Equity Holdings, Inc. 16.27 Million USD -405.525%
CareDx, Inc 277.76 Million USD 70.386%
Exact Sciences Corporation 2.06 Billion USD 96.008%
Exagen Inc. 52.29 Million USD -57.304%
Inotiv, Inc. 246.9 Million USD 66.684%
Guardant Health, Inc. 901.62 Million USD 90.877%
Biodesix, Inc. 77.41 Million USD -6.252%
BioNexus Gene Lab Corp. 3.92 Million USD -1996.793%
Precipio, Inc. 13.63 Million USD -503.16%
iSpecimen Inc. 16.27 Million USD -405.361%
Natera, Inc. 938.98 Million USD 91.24%
Aspira Women's Health Inc. 24.11 Million USD -241.125%
Standard BioTools Inc. 113.48 Million USD 27.518%
23andMe Holding Co. 420.73 Million USD 80.449%
Castle Biosciences, Inc. 242.78 Million USD 66.118%
Personalis, Inc. 128.14 Million USD 35.807%
Aclaris Therapeutics, Inc. 110.52 Million USD 25.574%
Applied DNA Sciences, Inc. 16.48 Million USD -398.941%
OpGen, Inc. 30.65 Million USD -168.312%
T2 Biosystems, Inc. 41.49 Million USD -98.243%
Myriad Genetics, Inc. 600.1 Million USD 86.292%
ICON Public Limited Company 755.64 Million USD 89.114%
NeoGenomics, Inc. 341.25 Million USD 75.895%
Star Equity Holdings, Inc. 16.27 Million USD -405.525%
IDEXX Laboratories, Inc. 1.09 Billion USD 92.473%
RadNet, Inc. 268.87 Million USD 69.407%
MDxHealth SA 71.25 Million USD -15.442%
Psychemedics Corporation 11.33 Million USD -625.772%
Illumina, Inc. 3.81 Billion USD 97.843%
Check-Cap Ltd. 19.28 Million USD -326.5%
Twist Bioscience Corporation 354.18 Million USD 76.775%
DarioHealth Corp. 62.17 Million USD -32.307%
Fulgent Genetics, Inc. 171.9 Million USD 52.149%
Sera Prognostics, Inc. 39.91 Million USD -106.075%
ENDRA Life Sciences Inc. 10.52 Million USD -681.875%
OPKO Health, Inc. 574.68 Million USD 85.686%
Medpace Holdings, Inc. 187.68 Million USD 56.171%
Neogen Corporation 405.23 Million USD 79.701%
Intelligent Bio Solutions Inc. 11.7 Million USD -602.54%
Prenetics Global Limited 60.73 Million USD -35.436%
Mainz Biomed B.V. 27.15 Million USD -202.931%
bioAffinity Technologies, Inc. 8.76 Million USD -838.511%
Trinity Biotech plc 46.49 Million USD -76.92%
Sotera Health Company 300.46 Million USD 72.623%
bioAffinity Technologies, Inc. 8.76 Million USD -838.511%